15 | Molecular effects of docosahexaenoic acid on carcinogenesis and tumor progression processes Rescigno T., Capasso A., Tecce Mm. |
100 | Mitochondrial network organization in cisplatin resistant cells Vianello C., Catanzaro D., Ragazzi E., Caparrotta L., Montopoli M. |
117 | Pharmacological blockade of A2B adenosine receptor reduces tumor angiogenesis and immunosuppression in a mouse model of melanoma Sorrentino C., Loffredo MT., Porta A., Pinto A., Morello S. |
149 | Effect of NO and H2S releasing doxorubicins on an in vitro model of colon cancer with MDR phenotype Cinci L., Chegaev K., Riganti C., Bigagli E., Luceri C. |
180 | Involvement of the L-cysteine/CSE/H2S pathway in human melanoma progression Armogida C., Panza E., De Cicco P., Ercolano G., Botti G., Papapetropoulos A., Cirino G., Ianaro A. |
193 | H2S-donors induce apoptosis of human melanoma cells Ercolano G., Panza E., Armogida C., De Cicco P., Sessa G., Pirozzi G., Papapetropoulos A., Cirino G., Ianaro A. |
202 | AOX-3 effects, a novel 5-lipoxygenase inhibitor, in breast cancer cells Ferraiolo FAV., Ciuffreda LP., Filosa R., Rivellino A., Berrino L. |
265 | In vitro and in vivo efficacy of an orally bioavailable antagonist of Eph-ephrin system in tumor angiogenesis and growth
Giorgio C., Castelli R., Hassan-Mohamed I., Incerti M., Vacondio F., Bertoni S., Festuccia C., Pala D., Lodola A., Barocelli E., Tognolini M. |
284 | The non-receptor tyrosine kinase Fes promotes the growth and the metastatic progression of neuroblastoma tumor Gnemmi I., Riva B., Condorelli F., Canonico PL. |
300 | NF-κB is a potential pharmacological target in triple negative breast cancers Labbozzetta M., Poma P., Vivona N., D'Alessandro N., Notarbartolo M. |
306 | The synergistic activity of irinotecan and sunitinib in anaplastic thyroid cancer: a new combined treatment approach Di Desidero T., Orlandi P., Fioravanti A., Danesi R., Bocci G. |
307 | Preclinical metronomic topotecan and pazopanib combination in primary or late stage metastatic triple-negative breast cancer Di Desidero T., Xu P., Man S., Kerbel RS., Bocci G. |
308 | Celecoxib Targets CML Blasts Proliferation in a COX-2 independent manner
Riva B., De Dominici M., Gnemmi I., Salomoni P., Canonico PL., Calabretta B., Condorelli F. |
320 | The oscillatory expression of ERα as a new drug target for resensitizing hormone-refractory breast cancer Dell'Omo G., Vantaggiato C., Villa A., Maggi A., Ciana P. |
328 | Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a new tumoural cytokine released from melanoma Torretta S., Travelli C., Amoruso A., Orsomando G., Canonico PL., Genazzani AA., Grolla AA. |
363 | Antiviral activity of different 1,4-dimethyl-9H-carbazoles Caporale A., Iacopetta D., Sinicropi MS., Caruso A., Mordocco R., Autore G., Saturnino C. |
373 | In vivo imaging of ER activation reveals an inflammatory switch as a common early pro-carcinogenesis step in breast tumorigenesis Vantaggiato C., Dell'Omo G., Gazzotti M., Capris I., Greco V., Maggi A., Ciana P. |
376 | Effects of CYP17A1 enzyme inhibition with Abiraterone Acetate in NCl-H295R, a Human Adrenocortical Cancer-Derived Cell Line Fragni M., Fiorentini C., Vezzoli S., Bonini SA., Missale C., Tiberio GAM., De Ferrari F., Memo M., Berruti A., Sigala S. |
385 | Atmospheric non-equilibrium plasma promotes cell death and cell-cycle arrest in a lymphoma cell line Catanzaro E., Turrini E., De Gianni E., Gherardi M., Laurita R., Stancampiano A., Colombo V., Fimognari C. |
409 | Dihydroxyphenylethanol, a product from olive oil, reduces colon cancer growth by enhancing EGFR degradation
Terzuoli E., Giachetti A., Bazzani L., Ziche M., Donnini S. |
416 | Amiloride in the management of the secondary mineralocorticoid excess syndrome induced by Abiraterone Acetate in Castration-Resistant Prostate Cancer (CRPC): in vivo and in vitro evidence Bedussi F., Galli D., Fragni M., Vezzoli S., Valcamonico F., Ferrari L., Dalla Volta A., De Ferrari F., Memo M., Berruti A., Sigala S. |
442 | EGF contributes to the pathogenesis of lymphangioleiomyomatosis by affecting ERK pathway Ancona S., Prinelli A., Chiaramonte E., Di Giulio AN., Gorio A., Pesenti C., Baisi A., Sirchia SM., Lesma E. |
443 | Molecular profile of tumor response to everolimus in different breast cancer cell lines Citi V., Del Re M., Martelli A., Palombi M., Testai L., Calderone V., Danesi R., Breschi MC. |
471 | Evaluation of inhibitory activity and selectivity of novel sulfasalazine analogues towards human glutathione transferases Calderan L., Di Paolo V., Castellano S., Balzano AL., Saggioro D., Ciancetta A., Deganutti G., Milite C., Sbardella G., Moro S., Quintieri L. |
476 | Effects of CB83 a new resorcinol-anandamide “hybrid” derivative on HT29 colon cancer cells Micheli L., Cerretani D., Fiaschi AI., Martino EC., Brizzi A., Pannini S., Passarello F., Lorè F., Menchiari A., Montefrancesco G., Giorgi G. |
478 | Vinorelbine metronomic chemotherapy for advanced tumor patients: observational study. Bertolaso L., Bononi A., Modena Y., Menon D., Barile C., Crepaldi G., Pasini F., Giusti P., Caruso D., Guesella M., Pezzolo E., Gaspardo A. |
448 | Effects of tyrosol and hydroxytyrosol in adenocarcinoma lung cancer cells exposed to hydrogen peroxide Gallelli L., Falcone D., Stefanelli R., Pelaia G., Maselli R., Savino R., Cione E., Caroleo M., De Sarro G. |
501 | Dual Actions of the Voltage-Dependent Potassium Channel Modulators on Cell Proliferation in SH-SY5Y Neuroblastoma Cells Curci A., Mele A., Maqoud F., Camerino GM., Zizzo N., Tricarico D. |
514 | Involvement of TRPM8 in colorectal cancer cell viability Finizio S., Pagano E., Romano B., Capasso R., Orlando P., Izzo AA., Borrelli F. |
548 | Characterization of the role of the endocannabinoid system in human melanoma cells Carpi S., Montagnani V., Stecca B., Polini B., Breschi MC., Nieri P., Fogli S. |
570 | Amphiphilic PLGA-poloxamer nanoparticles for the controlled release of silibinin Serri C., Giarra S., Mita DG., Saija A., De Rosa G., Mayol L., Biondi M. |
595 | Cytotoxic effect of Camptothecin nanosponges on anaplastic thyroid cancer cells in vitro and on orthotopic xenograft tumors in vivo Ferrara B., Gigliotti LC., Occhipinti S., Boggio E., Barrera G., Pizzimenti S., Giovarelli M., Fantozzi R., Chiocchetti A., Trotta F., Dianzani U., Cavalli R., Dianzani C. |
634 | The flavonoid fraction of mandarin juice acts as anti-proliferative and anti-migratory agent toward anaplastic thyroid carcinoma cells Cirmi S., Celano M., Maggisano V., De Rose RF., Bulotta S., Maiuolo J., Lombardo GE., Ferlazzo N., Russo D., Navarra M. |
632 | In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori
Ferlazzo N., Filocamo A., Bisignano C., Cirmi S., Mandalari G., Navarra M. |
635 | Growth inhibition, cell-cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells by bergamot juice Cirmi S., Ferlazzo N., Lombardo GE., Calapai G., Navarra M. |
674 | Hep G2 behaviour in 3D electrospun scaffolds as in vitro cancer inhibitor model Fasolino I., Guarino V., Cirillo V., Marrese M., Vallifuoco M., Tamma ML., Bracco A., Calise F., Ambrosio L. |
636 | In vitro antimicrobial activity of a white grape juice (Vitis vinifera) extract Cirmi S., Bisignano C., Filocamo A., Mandalari G., Lombardo GE., Ferlazzo N., Navarra M. |
610 | SR141716 exerts antitumor effect in colorectal cancer through WNT/β-Catenin-mediated pathway Proto MC., Fiore D., Pagano Zottola AC., Pisanti S., Ciaglia E., Picardi P., Malfitano AM., Laezza C., Bifulco M., Gazzerro P. |
604 | A role for DHA and aspirin-acetylated COX-2 metabolites on cancer related angiogenesis Vara-Messler M., Trenti A., Buccellati C., Sala A., Pasqualini ME., Trevisi L., Bolego C. |
687 | Bevacizumab and cetuximab in metastatic colorectal cancer in women and men: a retrospective multicentric study in Toscana Donnini S., Ettorre A., Paoletti D., Francini G., Gasperini G., Crispino S., Petrucci G., Lena F., Bengala C., Cecchi M., Antonuzzo L., Di Costanzo F., Giorgi S., Ziche M. |
684 | EGFR nuclear translocation in human lung cancer cells: role of Prostaglandin E2 Bazzani L., Finetti F., Donnini S., Ziche M. |
736 | “The dark side of Nrf2” A metabolomic pilot study about the role of the transcription factor NRF2 in glycolysis, in KrasG12D-driven non-small cell lung cancer mouse model Consolini N., Singh A., Lane A., Higashi R., Fan T., Biswal S., Hrelia P. |